Radiation therapy for retroperitoneal sarcoma.

Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.

Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.

Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.

[Anonymous].  2007.  Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.. Annals of surgical oncology. 14(7):2150-8.

ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.

Soft tissue sarcoma: preoperative and postoperative imaging for staging.

EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.

Radiofrequency ablation for unresectable tumors of the liver.

Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer.

Retroperitoneal and intra-abdominal sarcoma.

Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.